YAP1 and small cell lung carcinoma: The EV-derived circSH3PXD2A suppresses SCLC chemoresistance via the miR-375-3p/YAP1 axis. CircSH3PXD2A produced from EVs might act as a prognostic biomarker for DDP-resistant SCLC patients.